Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2016, Article ID 1592514, 6 pages
http://dx.doi.org/10.1155/2016/1592514
Research Article

Conjunctival Lymphangiogenesis Was Associated with the Degree of Aggression in Substantial Recurrent Pterygia

1Department of Ophthalmology, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou 510623, China
2Department of Ophthalmology, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510630, China

Received 1 November 2015; Revised 12 December 2015; Accepted 4 January 2016

Academic Editor: Neil Lagali

Copyright © 2016 Wei Zhao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. J. Janson and S. Sikder, “Surgical management of pterygium,” Ocular Surface, vol. 12, no. 2, pp. 112–119, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. I. Mohammed, “Treatment of pterygium,” Annals of African Medicine, vol. 10, no. 3, pp. 197–203, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Turan-Vural, B. Torun-Acar, S. A. Kivanc, and S. Acar, “The effect of topical 0.05% cyclosporine on recurrence following pterygium surgery,” Clinical Ophthalmology, vol. 5, no. 1, pp. 881–885, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. O. Yalcin Tok, A. Burcu Nurozler, G. Ergun, F. Akbas Kocaoglu, and S. Duman, “Topical cyclosporine A in the prevention of pterygium recurrence,” Ophthalmologica, vol. 222, no. 6, pp. 391–396, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. M. A. Ibáñez, M. F. Eugarrios, and D. I. Calderón, “Topical cyclosporin A and mitomycin C injection as adjunctive therapy for prevention of primary pterygium recurrence,” Ophthalmic Surgery, Lasers & Imaging, vol. 40, no. 3, pp. 239–244, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Livezeanu, M. M. Crăiţoiu, R. Mănescu, C. Mocanu, and Ş. Crăiţoiu, “Angiogenesis in the pathogenesis of pterygium,” Romanian Journal of Morphology and Embryology, vol. 52, no. 3, pp. 837–844, 2011. View at Google Scholar · View at Scopus
  7. S. Leippi, F. Grehn, and G. Geerling, “Antiangiogenic therapy for pterygium recurrence,” Ophthalmologe, vol. 106, no. 5, pp. 413–419, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Gumus, S. Karakucuk, G. E. Mirza, H. Akgun, H. Arda, and A. O. Oner, “Overexpression of vascular endothelial growth factor receptor 2 in pterygia may have a predictive value for a higher postoperative recurrence rate,” British Journal of Ophthalmology, vol. 98, no. 6, pp. 796–800, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. E. B. Ozgurhan, A. Agca, N. Kara, K. Yuksel, A. Demircan, and A. Demirok, “Topical application of bevacizumab as an adjunct to recurrent pterygium surgery,” Cornea, vol. 32, no. 6, pp. 835–838, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Nava-Castañeda, I. Ulloa-Orozco, L. Garnica-Hayashi, J. Hernandez-Orgaz, M. C. Jimenez-Martinez, and Y. Garfias, “Triple subconjunctival bevacizumab injection for early corneal recurrent pterygium: one-year follow-up,” Journal of Ocular Pharmacology and Therapeutics, vol. 31, no. 2, pp. 106–113, 2015. View at Publisher · View at Google Scholar
  11. S. Lee, J. Go, S. Rhiu et al., “Cosmetic regional conjunctivectomy with postoperative mitomycin C application with or without bevacizumab injection,” American Journal of Ophthalmology, vol. 156, no. 3, pp. 616.e3–622.e3, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. C. R. Rho, J. S. Choi, M. Seo, S. K. Lee, and C. K. Joo, “Inhibition of lymphangiogenesis and hemangiogenesis in corneal inflammation by subconjunctival Prox1 siRNA injection in rats,” Investigative Opthalmology & Visual Science, vol. 56, no. 10, pp. 5871–5879, 2015. View at Publisher · View at Google Scholar
  13. S.-Q. Ling, C. Liu, W.-H. Li, J.-G. Xu, and W.-H. Kuang, “Corneal lymphangiogenesis correlates closely with hemangiogenesis after keratoplasty,” International Journal of Ophthalmology, vol. 3, no. 1, pp. 76–79, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Cursiefen, K. Maruyama, D. G. Jackson, J. W. Streilein, and F. E. Kruse, “Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation,” Cornea, vol. 25, no. 4, pp. 443–447, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Cursiefen, U. Schlötzer-Schrehardt, M. Küchle et al., “Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin,” Investigative Ophthalmology and Visual Science, vol. 43, no. 7, pp. 2127–2135, 2002. View at Google Scholar · View at Scopus
  16. S. Ling, L. Liang, H. Lin, W. Li, and J. Xu, “Increasing lymphatic microvessel density in primary pterygia,” Archives of Ophthalmology, vol. 130, no. 6, pp. 735–742, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Lin, L. Luo, S. Ling et al., “Lymphatic microvessel density as a predictive marker for the recurrence time of pterygium: a three-year follow-up study,” Molecular Vision, vol. 19, pp. 166–173, 2013. View at Google Scholar · View at Scopus
  18. R. M. Awdeh, J. J. DeStafeno, D. M. Blackmon, T. J. Cummings, and T. Kim, “The presence of T-lymphocyte subpopulations (CD4 and CD8) in pterygia: evaluation of the inflammatory response,” Advances in Therapy, vol. 25, no. 5, pp. 479–487, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Banerji, J. Ni, S.-X. Wang et al., “LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan,” Journal of Cell Biology, vol. 144, no. 4, pp. 789–801, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. D. G. Jackson, “Biology of the lymphatic marker LYVE-1 and applications in research into lymphatic trafficking and lymphangiogenesis,” APMIS, vol. 112, no. 7-8, pp. 526–538, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Bono, V.-M. Wasenius, P. Heikkilä, J. Lundin, D. G. Jackson, and H. Joensuu, “High LYVE-1-positive lymphatic vessel numbers are associated with poor outcome in breast cancer,” Clinical Cancer Research, vol. 10, no. 21, pp. 7144–7149, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Nakao, K. Maruyama, S. Zandi et al., “Lymphangiogenesis and angiogenesis: concurrence and/or dependence? Studies in inbred mouse strains,” The FASEB Journal, vol. 24, no. 2, pp. 504–513, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. S. P. Patel and R. Dana, “Corneal lymphangiogenesis: implications in immunity,” Seminars in Ophthalmology, vol. 24, no. 3, pp. 135–138, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Regina, R. Zimmerman, G. Malik, and R. Gausas, “Lymphangiogenesis concurrent with haemangiogenesis in the human cornea,” Clinical & Experimental Ophthalmology, vol. 35, no. 6, pp. 541–544, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Ling, C. Qi, W. Li, J. Xu, and W. Kuang, “Crucial role of corneal lymphangiogenesis for allograft rejection in alkali-burned cornea bed,” Clinical & Experimental Ophthalmology, vol. 37, no. 9, pp. 874–883, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Dietrich, F. Bock, D. Yuen et al., “Cutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation,” The Journal of Immunology, vol. 184, no. 2, pp. 535–539, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. Ü. Beden, M. Irkeç, D. Orhan, and M. Orhan, “The roles of T-lymphocyte subpopulations (CD4 and CD8), intercellular adhesion molecule-1 (ICAM-1), HLA-DR receptor, and mast cells in etiopathogenesis of pterygium,” Ocular Immunology and Inflammation, vol. 11, no. 2, pp. 115–122, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. E. Ioachim-Velogianni, E. Tsironi, N. Agnantis, G. Datseris, and K. Psilas, “HLA-DR antigen expression in pterygium epithelial cells and lymphocyte subpopulations: an immunohistochemistry study,” German Journal of Ophthalmology, vol. 4, no. 2, pp. 123–129, 1995. View at Google Scholar · View at Scopus
  29. A. M. Cimpean, M. P. Sava, M. Raica, and D. Ribatti, “Preliminary evidence of the presence of lymphatic vessels immunoreactive for D2-40 and prox-1 in human pterygium,” Oncology Reports, vol. 26, no. 5, pp. 1111–1113, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Ling, Q. Li, H. Lin et al., “Comparative evaluation of lymphatic vessels in primary versus recurrent pterygium,” Eye, vol. 26, no. 11, pp. 1451–1458, 2012. View at Publisher · View at Google Scholar · View at Scopus